Quantification of Myocardial Contraction Fraction with Three-Dimensional Automated, Machine-Learning-Based Left-Heart-Chamber Metrics: Diagnostic Utility in Hypertrophic Phenotypes and Normal Ejection Fraction.
Andrea BarbieriJacopo Francesco ImbertiMario BartolomeiNiccolò BoniniVera LausLaura Torlai TrigliaSimona ChiusoloMarco StuaniChiara MariFederico MutoIlaria RighelliLuigi GerraMattia MalagutiDavide A MeiMarco VitoloGiuseppe BorianiPublished in: Journal of clinical medicine (2023)
Aims: The differentiation of left ventricular (LV) hypertrophic phenotypes is challenging in patients with normal ejection fraction (EF). The myocardial contraction fraction (MCF) is a simple dimensionless index useful for specifically identifying cardiac amyloidosis (CA) and hypertrophic cardiomyopathy (HCM) when calculated by cardiac magnetic resonance. The purpose of this study was to evaluate the value of MCF measured by three-dimensional automated, machine-learning-based LV chamber metrics (dynamic heart model [DHM]) for the discrimination of different forms of hypertrophic phenotypes. Methods and Results: We analyzed the DHM LV metrics of patients with CA ( n = 10), hypertrophic cardiomyopathy (HCM, n = 36), isolated hypertension (IH, n = 87), and 54 healthy controls. MCF was calculated by dividing LV stroke volume by LV myocardial volume. Compared with controls (median 61.95%, interquartile range 55.43-67.79%), mean values for MCF were significantly reduced in HCM-48.55% (43.46-54.86% p < 0.001)-and CA-40.92% (36.68-46.84% p < 0.002)-but not in IH-59.35% (53.22-64.93% p < 0.7). MCF showed a weak correlation with EF in the overall cohort (R 2 = 0.136) and the four study subgroups (healthy adults, R 2 = 0.039 IH, R 2 = 0.089; HCM, R 2 = 0.225; CA, R 2 = 0.102). ROC analyses showed that MCF could differentiate between healthy adults and HCM (sensitivity 75.9%, specificity 77.8%, AUC 0.814) and between healthy adults and CA (sensitivity 87.0%, specificity 100%, AUC 0.959). The best cut-off values were 55.3% and 52.8%. Conclusions: The easily derived quantification of MCF by DHM can refine our echocardiographic discrimination capacity in patients with hypertrophic phenotype and normal EF. It should be added to the diagnostic workup of these patients.
Keyphrases
- hypertrophic cardiomyopathy
- left ventricular
- ejection fraction
- breast cancer cells
- aortic stenosis
- machine learning
- heart failure
- cardiac resynchronization therapy
- acute myocardial infarction
- left atrial
- mitral valve
- magnetic resonance
- protein kinase
- deep learning
- artificial intelligence
- end stage renal disease
- atrial fibrillation
- chronic kidney disease
- single cell
- multiple myeloma
- structural basis